is there a patent on semaglutide New Delhi, March 19, 2026 – Friday, the key on semaglutide—the active molecule in Novo Nordisk's blockbuster drugs Ozempic and Wegovy—expired in India, marking pivotal shift in the country's Comprehensive Analysis of the Semaglutide
Pay in 4 interest-free payments of $6.86 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

)









:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)















